CHIME: Comparing Health Interventions for Maternal Equity
Launched by STANFORD UNIVERSITY · Dec 4, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The CHIME trial is studying different ways to help pregnant women and new mothers maintain a healthy weight during and after pregnancy. The main goal is to see which of two specific programs—both designed to offer support and guidance on nutrition and physical activity—works best in helping women reduce weight gained after childbirth. The trial will include women who are 18 years or older, currently pregnant with a single baby, and who identify as Black or Hispanic, or are on Medicaid.
Participants will be involved from early pregnancy until 12 months after giving birth and will attend five visits where they will answer questions, share details about their diet, and undergo some health measurements. This study aims to provide valuable insights into effective support for mothers, especially those facing barriers to healthy living. If you're interested and meet the eligibility criteria, you could play a crucial role in helping improve maternal health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Maternal age 18 years or older
- • Maternal gestational age ≤ 20 weeks with viable singleton pregnancy documented on first trimester ultrasound with an intention to continue pregnancy to term
- • Plans to continue receiving antenatal care at the recruitment site/network
- * Maternal characteristics include at least one of the following:
- • Self identifies as Black/African American
- • Self identifies as Hispanic/Latino/a/e/x
- • Insured by Medicaid
- • Maternal ability to speak English or Spanish
- • Completion of baseline data collection (maternal survey data, weight, and height measurement prior to randomization)
- Exclusion Criteria:
- • Age \< 18 years at baseline because of unique developmental differences of adolescents and regulations regarding age of consent
- • Underweight (BMI \<18 kg/m2) at pre-pregnancy period
- • Underlying disease/treatment that might impact weight status (e.g., significant gastrointestinal conditions, major psychiatric disorders, and others at the discretion of the study clinician)
- • Unwillingness or inability to complete study visits or intervention components
- • Unwillingness or inability to commit to intervention components for self or infant, including plans to move more than 100-mile radius from recruitment site
- • Multiple gestations
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported